Light‐chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome

MLA

Anahit Anvari-Pirsch, et al. “Light‐chain and Transthyretin Cardiac Amyloidosis in Severe Aortic Stenosis: Prevalence, Screening Possibilities, and Outcome.” European Journal of Heart Failure, vol. 22, Feb. 2020, pp. 1852–62. EBSCOhost, https://doi.org/10.1002/ejhf.1756.

APA

Anahit Anvari-Pirsch, Georg Goliasch, Julian Stiftinger, Christian Nitsche, Dietrich Beitzke, Irene Lang, Christina Binder, Julia Mascherbauer, Jolanta M. Siller-Matula, Diana Bonderman, Christian Loewe, Franz Duca, Christian Hengstenberg, Max-Paul Winter, Alexander Geppert, Thomas Poschner, Martin Andreas, Andreas A. Kammerlander, Renate Kain, … Hermine Agis. (2020). Light‐chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome. European Journal of Heart Failure, 22, 1852–1862. https://doi.org/10.1002/ejhf.1756

Chicago

Anahit Anvari-Pirsch, Georg Goliasch, Julian Stiftinger, Christian Nitsche, Dietrich Beitzke, Irene Lang, Christina Binder, et al. 2020. “Light‐chain and Transthyretin Cardiac Amyloidosis in Severe Aortic Stenosis: Prevalence, Screening Possibilities, and Outcome.” European Journal of Heart Failure 22 (February): 1852–62. doi:10.1002/ejhf.1756.